Discover it Now!
The Ovarian Cancer Commitment (OCC) is an initiative launched by the European Society of Gynaecological Oncology (ESGO), the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) and AstraZeneca.
View Press Release
We are committed to creating a movement in ovarian cancer care through highlighting the importance of improving access to rapid diagnosis, biomarker testing and specialised care, to ultimately facilitate the improvement of the quality of life of women* living with ovarian cancer.
The OCC will provide a platform to current and future partners to pledge their commitment and implement tangible actions to help improve the experience and survival of those living with ovarian cancer.
For more information, please visit: www.ovariancancercommitment.com
*This refers to people assigned female at birth
Find out more
Support ESGO educational activities and help us develop more opportunities for colleagues from low resource areas.
"The OCC seeks to address the many challenges women with ovarian cancer face, to increase knowledge and access to best care, in order to ultimately improve survival and support better quality of life for ovarian cancer patients.." Prof. Nicole Concin, ESGO President Watch Video
"The OCC seeks to address the many challenges women with ovarian cancer face, to increase knowledge and access to best care, in order to ultimately improve survival and support better quality of life for ovarian cancer patients.."
Prof. Nicole Concin, ESGO President
Watch Video
"The OCC recognises the power of community and will act as a collective voice for everyone diagnosed with ovarian cancer, providing a vital opportunity for their views to be heard and connect people, information and resources. I do believe that together we can drive forward better outcomes.” Petra Adamkova, Co-Chair, ENGAGe Watch Video
"The OCC recognises the power of community and will act as a collective voice for everyone diagnosed with ovarian cancer, providing a vital opportunity for their views to be heard and connect people, information and resources. I do believe that together we can drive forward better outcomes.”
Petra Adamkova, Co-Chair, ENGAGe
“We are proud to join forces with the wider community to drive progress in the understanding, management and outcomes of ovarian cancer. Although significant progress has been made in recent decades, ovarian cancer is a complex problem that can only be solved through collaboration.” Dave Fredrickson, EVP Oncology Business Unit, AstraZeneca Watch Video
“We are proud to join forces with the wider community to drive progress in the understanding, management and outcomes of ovarian cancer. Although significant progress has been made in recent decades, ovarian cancer is a complex problem that can only be solved through collaboration.”
Dave Fredrickson, EVP Oncology Business Unit, AstraZeneca
06.11.2023 - 07.11.2023 IRCAD, Strasbourg, France Level: Advanced
Learn more
28.09. - 01.10.2023 Istanbul, Türkiye
07.12.2023 - 12.01.2024 Online | Madrid, Spain Level: Advanced